The patient population included in the present study was representative of a population with EGFR-mutated advanced nonsquamous NSCLC, namely, including more women (66%) than men, more Asian patients (15%) than in other US real-world studies not restricted to EGFR-mutated NSCLC, and more nonsmokers (57%) than smokers (3, 6, 42). Here, EGFR is linked to non-small cell lung carcinoma.